HOME >> BIOLOGY >> NEWS
Malaria in pregnancy: What can the social sciences contribute?

Most malaria deaths worldwide are in children under 5 years old and pregnant women. While there has been a large amount of social science research on children and malaria, malaria in pregnancy has received little attention from social scientists, say researchers in a policy paper in PLoS Medicine.

Building on existing knowledge from social science research on malaria, Professor Umberto D'Alessandro (Institute of Tropical Medicine, Antwerp, Belgium) and colleagues propose two models for studying the social science aspects of malaria in pregnancy. One model considers social factors in malaria prevention, and the other in malaria treatment.

Citation: Ribera JM, Hausmann-Muela S, D'Alessandro U, Grietens KP (2007) Malaria in pregnancy: What can the social sciences contribute? PLoS Med 4(4): e92.

PLEASE ADD THE LINK TO THE PUBLISHED ARTICLE IN ONLINE VERSIONS OF YOUR REPORT: http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.0040092

PRESS-ONLY PREVIEW OF THE ARTICLE: http://www.plos.org/press/plme-04-04-d'alessandro.pdf

Related images for press use:

http://www.plos.org/press/plme-04-04-d'alessandro-figure-1.pdf

- Caption: The Malaria in Pregnancy Treatment Model

http://www.plos.org/press/plme-04-04-d'alessandro-figure-2.pdf

- Caption: The Malaria in Pregnancy Prevention Model

CONTACT:
Umberto D'Alessandro
Prince Leopold Institute of Tropical Medicine
Parasitology
Nationalestraat 155
Antwerp, B-2000
Belgium
+32 3 247 63 54
+32 3 247 63 59 (fax) <
'"/>

Contact: Andrew Hyde
press@plos.org
44-122-346-3330
Public Library of Science
9-Apr-2007


Page: 1 2

Related biology news :

1. Malaria -- Effective insecticide-repellent synergy against mosquito vectors
2. Malaria-resistant mosquitoes battle disease with molecular warhead
3. Malaria and Epstein-Barr virus linked to pediatric cancer in Africa
4. Malaria: The right vaccine in the right place?
5. PATH Malaria Vaccine Initiative announces partnership to develop novel malaria vaccine
6. 20 Years of Malaria Research: Outcomes and Perspectives
7. Malaria poses additional risks for first-time mothers
8. Malaria drug may treat metabolic syndromes many symptoms
9. Malaria: Efficacy of monotherapies in Cameroon
10. Malaria, potato famine pathogen share surprising trait
11. Malaria parasite impairs key immune system cells

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/14/2019)... ... August 14, 2019 , ... ... explore how developments in microbiome therapeutics are helping to promote normal immune function ... information. , Advancements will educate about the DECODE.DESIGN.CURE™ technology platform, which rapidly develops ...
(Date:8/14/2019)... TORONTO (PRWEB) , ... August 13, 2019 , ... ... Cancer Medicine Team, Division of Molecular Pathology, Institute of Cancer Research (ICR) in ... (5pm BST/UK) to learn about the process of biomarker and companion diagnostic development ...
(Date:8/6/2019)... ... August 05, 2019 , ... Keck Graduate Institute (KGI) President ... Pharmacy and Health Sciences (SPHS). , “Dean Zdanowicz is highly regarded as an innovative ... Jim Widergren. “He is a great choice to build on the success of the ...
Breaking Biology News(10 mins):
(Date:6/11/2019)... , ... June 10, 2019 , ... ... and technology in an upcoming episode, scheduled to broadcast 4Q/2019. Check your local ... Group) and will educate viewers about how its technology facilitates laboratories to improve ...
(Date:6/11/2019)... Md. and ROANOKE, Va. (PRWEB) , ... June ... ... care optimized for microlearning engagement, and Carilion Clinic, a national leader in opioid ... the latest in virtual care. , Mytonomy recently deployed its virtual ...
(Date:6/11/2019)... N.C. (PRWEB) , ... June 11, 2019 , ... ... extracellular vesicles derived from human mesenchymal stem cells (MSC-EV) are able to incorporate ... cloning ability. In a test on mice, MSC-EVs also increased the cells’ ability ...
(Date:5/31/2019)... ... , ... For many years, the primary forms of cancer treatment have been ... in immuno-oncology have led to the advent of Chimeric Antigen Receptor T (CAR T) ... known as “CARs”. The CAR enables the final product to produce chemicals in the ...
Breaking Biology Technology:
Cached News: